Close

Professor Hazel Dockrell

BA PhD

Professor
of Immunology, Special Advisor on Overseas Partnerships in Africa

Room
286

LSHTM
Keppel Street
London
WC1E 7HT
United Kingdom

Tel.
020 7927 2466

I initially did a BA degree in Microbiology at Trinity College Dublin, followed by a PhD in autoimmunity at the Royal Dental Hospital of London. After a period as a postdoc at the Middlesex Hospital Medical School working on malaria, I moved to the LSHTM in 1985. Initially I was working on the immunology of leprosy but this then led me into tuberculosis, BCG vaccination and biomarkers. I now also help as Special Advisor on our Overseas Programmes in Africa.

Affiliations

Executive Office
Department of Infection Biology
Faculty of Infectious and Tropical Diseases

Centres

Tuberculosis (TB) Centre
Vaccine Centre

Teaching

With members of my research group, I teach and tutor on the MSc Immunology of Infectious Diseases course.

Research

Our research aims to understand the basis of protective immunity against tuberculosis and in particular to identify biomarker signatures that would help in the development of new TB vaccines. We are also interested in how TB treatment modulates immune and gene expression signatures, and in how co-morbidity with helminth infections or diabetes impact on immunity to Mycobacterium tuberculosis.

Research Area
Helminths
T-cell immunology
Vaccines
Capacity strengthening
Global Health
Immunisation
Discipline
Immunoepidemiology
Immunology
Vaccinology
Disease and Health Conditions
Infectious disease
Leprosy
Tuberculosis
Chronic Fatigue Syndrome
Diabetes
Country
Ethiopia
United Kingdom
Indonesia
Korea, Rep.
Pakistan
Romania
Uganda
South Africa
Region
East Asia & Pacific (all income levels)
European Union
Sub-Saharan Africa (all income levels)

Selected Publications

Point of care HbA1c level for diabetes mellitus management and its accuracy among tuberculosis patients: a study in four countries.
Huangfu P; Laurence YV; Alisjahbana B; Ugarte-Gil C; Riza A-L; Walzl G; Ruslami R; Moore DAJ; Ioana M; McAllister S
2019
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
In vitro mycobacterial growth inhibition in South Korean adults with latent TB infection
Lee H; Kim J; Kang YA; Kim DR; Sim B; Zelmer A; Fletcher HA; Dockrell HM; Smith SG; Cho S-N
2019
Frontiers in Immunology
Cellular immune function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Cliff JM; King EC; Lee J-S; SepĂșlveda N; Wolf A-S; Kingdon C; Bowman E; Dockrell HM; Nacul L; Lacerda E
2019
Frontiers in Immunology
A Feasibility Study for Diagnosis of Latent Tuberculosis Infection Using an IGRA Point-of-Care Platform in South Korea.
Hur YG; Hong JY; Choi DH; Kim A; Park SY; Kwon M; Kang K; Lee JM; Dockrell HM; Lee Y
2019
Yonsei medical journal
Immunometabolic Signatures Predict Risk of Progression to Active Tuberculosis and Disease Outcome
Duffy FJ; Weiner J; Hansen S; Tabb DL; Suliman S; Thompson E; Maertzdorf J; Shankar S; Tromp G; Parida S
2019
FRONTIERS IN IMMUNOLOGY
Distinct serum biosignatures are associated with different tuberculosis treatment outcomes.
Ronacher K; Chegou NN; Kleynhans L; Djoba Siawaya JF; du Plessis N; Loxton AG; Maasdorp E; Tromp G; Kidd M; Stanley K
2019
Tuberculosis
Evidence of Clinical Pathology Abnormalities in People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) from an Analytic Cross-Sectional Study.
Nacul L; de Barros B; Kingdon CC; Cliff JM; Clark TG; Mudie K; Dockrell HM; Lacerda EM
2019
Diagnostics (Basel, Switzerland)
Diabetes mellitus among pulmonary tuberculosis patients from four TB-endemic countries: the TANDEM study.
Ugarte-Gil C; Alisjahbana B; Ronacher K; Riza AL; Koesoemadinata RC; Malherbe ST; Cioboata R; Llontop JC; Kleynhans L; Lopez S
2019
Clinical infectious diseases
See more Publications